Recent regulatory developments in EU Medical Device Regulation and their impact on biomaterials translation
Bioengineering & Translational Medicine · 2025-03 · 10 (2)
DOI: 10.1002/btm2.10721 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 16.10.2024. Verfasst von Klaudia M Jurczak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biomaterials and Biomedical Technology Department-FB40 University of Groningen, University Medical Center Groningen Groningen The Netherlands. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jaap Schouten Foundation.
Abstract (Originalsprache)
We envision this work to assist researchers and medical device developers (beside other stakeholders) to better understand biomaterial‐based medical device development and its approval process proposed by the new MDR and IVDR in the European Union, as more complex biomaterials emerge, with the MDR reflecting the progress in biomaterial discoveries. Additionally, insufficient international harmonization in regulatory laws and poor‐quality data reporting contribute to the problem. This review describes the possible reasons for a slowing biomaterials translational trend observed over the past decades, focusing on the European Market, and suggests a feasible approach for biomaterials‐based medical device translation into the clinic. Suitable solutions to upgrade biomaterial translation to the clinic have not yet been provided by the field: no additional hurdles should be imposed for researchers, clinicians, the medical device industry, and insurance companies, which all should collaborate on bringing innovative solutions to patients. The new MDR and IVDR represent a substantial advancement in ensuring patient safety and reflect a major step forward in healthcare. However, they should not constrain innovation in biomaterials‐based medical device development. Incorporating reverse engineering from patient safety and a ‘safe by design’ (SbD) strategy early into medical device development might lead to a smoother and successful approval process. A solid R&D phase, with an emphasis on device safety and performance assessment, is fundamental to ensure an effective transition into the clinic. We offer an overview of the recently implemented regulations on medical devices and in vitro diagnostics across the EU, describing a shifting paradigm in the field of biomaterials discovery. As more complex biomaterials emerge, suitable regulations will be necessary to keep bringing safe and well‐performing medical solutions to patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomaterials and Biomedical Technology Department-FB40 University of Groningen, University Medical Center Groningen Groningen The Netherlands.
- Department of Surgery, Division of Vascular Surgery University Medical Centre Groningen, University of Groningen Groningen The Netherlands.
- Quality and Safety University Medical Center Groningen Groningen The Netherlands.
ORCID-Profile: Patrick van Rijn
Förderung
- Jaap Schouten Foundation
Zitieren
APA
Jurczak, K. M., van der Boon, T. A. B., Devia-Rodriguez, R., Schuurmann, R. C. L., Sjollema, J., van Huizen, L., De Vries, J. P. M., & van Rijn, P. (2025). Recent regulatory developments in EU Medical Device Regulation and their impact on biomaterials translation. Bioengineering & Translational Medicine, 10(2). https://doi.org/10.1002/btm2.10721
Vancouver
Jurczak KM, van der Boon TAB, Devia-Rodriguez R, Schuurmann RCL, Sjollema J, van Huizen L, et al. Recent regulatory developments in EU Medical Device Regulation and their impact on biomaterials translation. Bioengineering & Translational Medicine. 2025;10(2). doi:10.1002/btm2.10721
BibTeX
@article{Jurczak2025,
author = {Jurczak, Klaudia M and van der Boon, Torben A B and Devia-Rodriguez, Raul and Schuurmann, Richte C L and Sjollema, Jelmer and van Huizen, Lidia and De Vries, Jean-Paul P M and van Rijn, Patrick},
title = {Recent regulatory developments in EU Medical Device Regulation and their impact on biomaterials translation},
journal = {Bioengineering & Translational Medicine},
year = {2025},
volume = {10},
number = {2},
doi = {10.1002/btm2.10721}
}
EUVIMED